Keyword Search
Keyword=clinical trials

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2003 Program page
  301092  By:  Jeff Sloan 2:05 PM 08/03/2003
Methods for Assessing Clinical Significance in Quality of Life Measurement

  300320  By:  Scott Emerson 2:35 PM 08/03/2003
Evaluating a Group Sequential Design in the Setting of Nonproportional Hazards

  301821  By:    2:50 PM 08/03/2003
Designs, Power, and Sample Size for a NonStop Drug Development Strategy

  301886  By:  Scott Emerson 2:50 PM 08/03/2003
Evaluation Criteria for Orderings of Group Sequential Statistics

  301009  By:    4:35 PM 08/03/2003
Evaluating Multiple Endpoints Collectively

  302112  By:    4:50 PM 08/03/2003
Ethical Issues in Data Monitoring of Clinical Trials

  300678  By:    08/04/2003    ML02
ML02   Adjustment for Covariates in Randomized Clinical Trials: A Regulator's Perspective - THIS LUNCHEON IS SOLD OUT

  300992  By:    08/04/2003    ML04
ML04   Impact of Secondary Endpoint Multiplicity Issues on Drug Development Programs - THIS LUNCHEON IS SOLD OUT

  300813  By:  Roderick Little 8:35 AM 08/04/2003
Causal Inference in Choice-Based Intervention Studies

  302251  By:  Sarah Kogut 8:35 AM 08/04/2003
Missing Values Strategies in Medical Device Clinical Trials

  300019  By:    2:20 PM 08/04/2003
Including Multiple Imputation in a Sensitivity Analysis for Clinical Trials with Treatment Failures

  300046  By:  Geert Molenberghs 2:35 PM 08/04/2003
Analyzing Incomplete Longitudinal Clinical Trial Data

  301582  By:    2:50 PM 08/04/2003
Can Interim + Imputation = Final?

  301545  By:    3:20 PM 08/04/2003
A Comparison Between Andersen-Gill and Lin-Wei-Yang-Ying Model for Hypoglycemia Data

  301166  By:    08/05/2003
Actual Change Versus Percentage Change as an Endpoint in Clinical Trials

  300532  By:    08/05/2003
A Weighted Imputation Technique Using Stratified Weighted Means

  300676  By:    08/05/2003
Probability Models and Computational Models for ANOVA in Multicenter Trials

  300682  By:    8:50 AM 08/05/2003
Robust Bayesian Randomized Clinical Trials

  301710  By:  Alexia Iasonos 10:05 AM 08/05/2003
QoL in Oncology: A Review of Several Models in the Area Under the Curve Analysis

  300810  By:    08/06/2003    WL02
WL02   Standard Operating Procedures (SOPs) From a Statistician's Perspective - THIS LUNCHEON IS SOLD OUT

  301465  By:  Gregory Campbell 08/06/2003    WL04
WL04   Statistical Issues in Medical Device Studies - THIS LUNCHEON IS SOLD OUT

  300488  By:  Yonghang (Fred) Yang 10:50 AM 08/06/2003
Assessment of Adverse Events in Titration Studies

  301841  By:    11:35 AM 08/06/2003
Statistical Analysis of Cardiac Allograft Vasculopathy Using Intravascular Ultrasound

  301217  By:  Michael Nessly 2:50 PM 08/06/2003
Regression to the Mean in HIV Clinical Trials

  301956  By:    8:35 AM 08/07/2003
Adjustment for Center Effects in Clinical Trials Data Analysis

  301704  By:    11:50 AM 08/07/2003
Alpha Allocation and Interpretation of Composite Endpoints in Clinical Trials

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003